Join
Live feed
·
PRReleasevia Quantisnow
Oyster Point Pharma Inc. logo

Oyster Point Pharma Announces FDA Approval of TYRVAYA™ (varenicline solution) Nasal Spray for the Treatment of the Signs and Symptoms of Dry Eye Disease

ByQuantisnow·Wall Street's wire, on your screen.
OYST· Oyster Point Pharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OYST (Oyster Point Pharma Inc.) and more on Quantisnow.